title: Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
abstract: Tyrosine kinase inhibitors represent today's treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as salvage therapy. This prospective randomized CML-study IIIA recruited 669 patients with newly diagnosed CML between July 1997 and January 2004 from 143 centers. Of these, 427 patients were considered eligible for HSCT and were randomized by availability of a matched family donor between primary HSCT (group A; N=166 patients) and best available drug treatment (group B; N=261). Primary end point was long-term survival. Survival probabilities were not different between groups A and B (10-year survival: 0.76 (95% confidence interval (CI): 0.69-0.82) vs 0.69 (95% CI: 0.61-0.76)), but influenced by disease and transplant risk. Patients with a low transplant risk showed superior survival compared with patients with high- (P<0.001) and non-high-risk disease (P=0.047) in group B; after entering blast crisis, survival was not different with or without HSCT. Significantly more patients in group A were in molecular remission (56% vs 39%; P=0.005) and free of drug treatment (56% vs 6%; P<0.001). Differences in symptoms and Karnofsky score were not significant. In the era of tyrosine kinase inhibitors, HSCT remains a valid option when both disease and transplant risk are considered.
authors.affiliation: Klinik für Hämatologie, Universitätsspital Basel, Basel, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
authors.affiliation: Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, München, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Pfirrmann
authors.affiliation: Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Zander
authors.affiliation: Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Kröger
authors.affiliation: Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Essen, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Beelen
authors.affiliation: Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Essen, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Novotny
authors.affiliation: Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Klinikum Schwabing München, München, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Nerl
authors.affiliation: Klinik I für Innere Medizin, Universitätsklinikum Köln, Köln, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Scheid
authors.affiliation: Medizinische Klinik III und Poliklinik, Universitätsklinikum München, München, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Spiekermann
authors.affiliation: Department of Internal Medicine, Hemato-Oncology, University Hospital and Masaryk University, Brno, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Mayer
authors.affiliation: Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
authors.forename: H G
authors.initials: HG
authors.lastname: Sayer
authors.affiliation: Medizinische Klinik 5, Klinikum Nürnberg-Nord, Nürnberg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Falge
authors.affiliation: Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Bunjes
authors.affiliation: Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Döhner
authors.affiliation: Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Ganser
authors.affiliation: Zentrum für Integrierte Onkologie (CIO), Universitätsklinikum Bonn, Bonn, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Schmidt-Wolf
authors.affiliation: KMT-Zentrum, Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Schwerdtfeger
authors.affiliation: KMT-Zentrum, Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Baurmann
authors.affiliation: Abteilung für Hämatologie und Stammzelltransplantation, Asklepios Klinik St Georg, Hamburg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Kuse
authors.affiliation: Abteilung für Hämatologie und Stammzelltransplantation, Asklepios Klinik St Georg, Hamburg, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Schmitz
authors.affiliation: Klinik für Hämatologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Wehmeier
authors.affiliation: II. Medizinische Klinik, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
authors.forename: J Th
authors.initials: JT
authors.lastname: Fischer
authors.affiliation: Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
authors.forename: A D
authors.initials: AD
authors.lastname: Ho
authors.affiliation: Medizinische Klinik 5, Klinikum Nürnberg-Nord, Nürnberg, Germany.|Medizinische Klinik und Poliklinik, Universitätsklinikum Würzburg, Würzburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Wilhelm
authors.affiliation: Medizinische Klinik und Poliklinik, Universitätsklinikum Würzburg, Würzburg, Germany.
authors.forename: M-E
authors.initials: ME
authors.lastname: Goebeler
authors.affiliation: Klinik für Hämatologie und Onkologie, St-Marien-Hospital Hagen, Hagen, Germany.
authors.forename: H W
authors.initials: HW
authors.lastname: Lindemann
authors.affiliation: I. Medizinische Klinik, Klinikum Bremen-Mitte, Bremen, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Bormann
authors.affiliation: I. Medizinische Klinik, Klinikum Bremen-Mitte, Bremen, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Hertenstein
authors.affiliation: II. Medizinische Klinik, Klinikum Augsburg, Augsburg, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Schlimok
authors.affiliation: Universitätsklinik für Hämatologie, Inselspital Bern, Bern, Switzerland.
authors.forename: G M
authors.initials: GM
authors.lastname: Baerlocher
authors.affiliation: Klinik für Onkologie und Hämatologie, HELIOS St Johannes Klinik Duisburg, Duisburg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Aul
authors.affiliation: Klinik für Innere Medizin I, Universität des Saarlandes, Homburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Pfreundschuh
authors.affiliation: Medizinische Klinik I, Bürgerhospital Stuttgart, Stuttgart, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Fabian
authors.affiliation: Klinik für Hämatologie und Onkologie, St Antonius Hospital Eschweiler, Eschweiler, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Staib
authors.affiliation: Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Regensburg, Regensburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Edinger
authors.affiliation: II. Medizinische Klinik, St Vincentius Kliniken, Karlsruhe, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Schatz
authors.affiliation: Klinik für Knochenmarktransplantation und Hämatologie/Onkologie, Idar-Oberstein, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Fauser
authors.affiliation: Medizinische Klinik mit Schwerpunkt Hämatologie, Virchow-Klinikum, Charité-Universitätsmedizin, Berlin, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Arnold
authors.affiliation: III. Medizinische Klinik, Universitätsmedizin Mainz, Mainz, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Kindler
authors.affiliation: Klinik für Hämatologie und Onkologie, Universitätsmedizin Göttingen, Göttingen, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Wulf
authors.affiliation: Division d'Hematologie, CHUV, Lausanne, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Rosselet
authors.affiliation: Department of Hematology, Medical University of Gdansk, Gdańsk, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Hellmann
authors.affiliation: Onkologische Schwerpunktpraxis, Bielefeld, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Schäfer
authors.affiliation: Klinik für Innere Medizin III, Klinikum Kempten-Oberallgäu, Kempten, Germany.
authors.forename: O
authors.initials: O
authors.lastname: Prümmer
authors.affiliation: Klinik für internistische Onkologie und Hämatologie, Krankenhaus Barmherzige Brüder, Regensburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Schenk
authors.affiliation: Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, München, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Hasford
authors.affiliation: Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Heimpel
authors.affiliation: Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: D K
authors.initials: DK
authors.lastname: Hossfeld
authors.affiliation: Medizinische Klinik III und Poliklinik, Universitätsklinikum München, München, Germany.
authors.forename: H-J
authors.initials: HJ
authors.lastname: Kolb
authors.affiliation: Institut für Pathologie, Medizinische Hochschule, Hannover, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Büsche
authors.affiliation: MLL Münchner Leukämielabor GmbH, München, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Haferlach
authors.affiliation: MLL Münchner Leukämielabor GmbH, München, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Schnittger
authors.affiliation: III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität, Heidelberg, Germany.
authors.forename: M C
authors.initials: MC
authors.lastname: Müller
authors.affiliation: III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität, Heidelberg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Reiter
authors.affiliation: III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität, Heidelberg, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Berger
authors.affiliation: III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität, Heidelberg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Saußele
authors.affiliation: Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.|III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität, Heidelberg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Hochhaus
authors.affiliation: III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität, Heidelberg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005190:Family; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012074:Remission Induction; D012306:Risk; D016019:Survival Analysis; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate